Elizabeth Ann Altman serves as Executive at CV Sciences, Inc., where they oversee executive responsibilities. Since joining the company, Elizabeth Ann Altman has executed 13 insider transactions totaling $534.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 31, 2024 involved receiving (via award) 42,106 shares valued at $0.
Elizabeth Ann Altman currently holds 77,658 shares of CV Sciences, Inc. (CVSI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elizabeth Ann Altman has been a net seller of CVSI stock. They have purchased $5.0K and sold $529.4K worth of shares.
Elizabeth Ann Altman's most recent insider trade was on May 31, 2024, when they sold 42,106 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 16, 2023 | ATEC | $149.7K | Sale | 9,273 | $16.14 | Planned |
| Aug 17, 2022 | ATEC | $72.6K | Sale | 8,009 | $9.06 | Discretionary |
| Jun 27, 2022 | MDRX | $0 | Award | 12,756 | $N/A | Discretionary |
| Jun 15, 2022 | ATEC | $0 | Award | 18,546 | $N/A | Discretionary |
| May 27, 2022 | MDRX | $101.0K | Sale | 6,028 | $16.75 | Discretionary |
| Aug 12, 2021 | ATEC | $0 | Award | 8,870 | $N/A | Discretionary |
| Aug 12, 2021 | ATEC | $0 | Award | 21,024 | $N/A | Discretionary |
| Jun 14, 2021 | MDRX | $206.2K | Sale | 11,600 | $17.78 | Discretionary |
| May 25, 2021 | MDRX | $0 | Award | 12,056 | $N/A | Discretionary |
| Jun 4, 2020 | MDRX | $0 | Award | 28,368 | $N/A | Discretionary |
| Jun 20, 2019 | CVSI | $5.0K | Purchase | 1,181 | $4.24 | Discretionary |